Bruker (BRKR) Divestments (2013 - 2014)
Bruker posted quarterly Divestments of $12.5 million for Q4 2014, up 3.31% on a QoQ basis from $12.1 million in Q3 2014.
Bruker (BRKR) has 2 years of Divestments data on file, last reported at $12.5 million in Q4 2014.
- For the quarter ending Q4 2014, Divestments changed N/A year-over-year to $12.5 million; the trailing twelve-month figure through Dec 2014 stood at $25.3 million (up 4960.0% YoY), and the FY2015 full-year result was $200000.0, down 99.21% from the prior year.
- Divestments for Q4 2014 stood at $12.5 million, up from $12.1 million in the prior quarter.
- Across five years, Divestments topped out at $12.5 million in Q4 2014 and bottomed at $500000.0 in Q1 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 12.50 Mn |
| Sep 30, 2014 | 12.10 Mn |
| Mar 31, 2014 | 700,000.00 |
| Mar 31, 2013 | 500,000.00 |